– “RAYMO”, an FDA-approved and CE-certified mobile DR system, makes its debut in India
– Enhancing imaging convenience and mobility stability with its compact design and user-customizable features
DRGEM (263690, CEO J. B. Park), a global medical imaging solutions company, is set to enter the Indian medical imaging market with its next-generation mobile DR system. DRGEM announced that it will participate in the medical device exhibition “India Health 2026,” taking place from August 21 to 23 at Bharat Mandapam in New Delhi, India, where it will unveil its mobile DR system, “RAYMO,” to the Indian market for the first time.
Through this exhibition, DRGEM plans to expand its network with local medical institutions and partners and strengthen its brand presence in the Indian market. In particular, the company plans to showcase RAYMO, which enhances imaging efficiency in clinical settings, to highlight DRGEM’s capabilities in mobile medical imaging solutions.
RAYMO is a mobile DR system that has received approval from the U.S. Food and Drug Administration (FDA) and CE certification in Europe. Its compact design incorporates RFID-based automatic adjustments for the monitor angle and driving handle height tailored to each user, as well as automatic software settings, maximizing imaging convenience. It also features a smooth ride and a built-in camera, significantly enhancing stability during equipment movement.
J. B. Park, CEO of DRGEM, stated, “This exhibition, which marks the first introduction of RAYMO to the Indian market, is a meaningful opportunity to directly showcase DRGEM’s mobile medical imaging technology to local customers,” adding, “We will continue to expand our presence in the local market based on differentiated solutions that address the diverse needs of the Indian healthcare sector.” India Health 2026 will be held from August 21 to 23 at the Bharat Mandapam in New Delhi, India. DRGEM plans to exhibit RAYMO at Booth B38, where it will conduct product demonstrations and consultations.
